NYSE American · APTHealthcareOrthopedic & Surgical Supplies

Alpha Pro Tech, Ltd. (APT)

$5.71+2.70%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$5.56▲ 20.35% in range
Nov 3, 2025Low $4.34 · High $6.64Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

Alpha Pro Tech closed at $5.71 on Nov 4, up 2.70%, 14.0% below its 52-week closing high. Volume of 8.8K shares was 0.17× its 20-day average (below normal).

Split-adjusted performance: -4.7% over one month, +21.5% over six months, +23.6% over one year.

In the quarter ended Jun 30, 2026, revenue was $18.67M, up 12.0% from a year earlier, with a net margin of 9.8%.

Short interest was 82.9K shares at the Oct 15 settlement, up 85.8% from the prior report (1.0% of float, 1.0 days to cover).

Market cap$58.3M10.2M shares
Revenue · quarter$18.7M+12.0% YoY
Diluted EPS$0.18+50.0% YoY
P/E · TTM13.9×P/S 0.9×
Net margin9.8%Gross 37.4%
Dividend yieldNone
52-week range4.34 – 6.64−14.0% from high
Volume8.8K0.17× 20-day avg
Volatility · 60d40.8%Annualised
Short % of float1.0%1.0 days to cover
Net cash$18.9MCash $18.9M
Next earnings—Not scheduled
Split-adjusted performance
1W +4.2%1M −4.7%3M +9.4%6M +21.5%YTD +28.6%1Y +23.6%3Y +41.0%5Y −4.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Orthopedic & Surgical Supplies

Percentile among 22 companies (100 = best)

6-month momentum80
Revenue growth47
Net margin74
Value (low P/E)100
Size24

Industry medians: 6-month return +1.5%, revenue growth +12.8%, net margin −2.8%, P/E 29.2×.

Short interest

Details →
Shares short82.9K+85.8% vs prior
Days to cover1.0Settled Oct 15
% of float1.0%
Short vol. 10d56.4%of daily volume

Closest peers by size in Orthopedic & Surgical Supplies

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
APTAlpha Pro Tech$5.71+2.70%+21.5%+12.0%9.8%13.9$58.3M
COCHEnvoy Medical$6.88+3.85%+1.8%−34.6%−14258.8%—$53.2MCompare
SPAISafe Pro Group$3.25+2.52%−27.3%+1336.2%−237.9%—$66.2MCompare
MYOMyomo$1.29+0.78%+51.2%+21.3%−34.4%—$51.1MCompare
CNXUConexeu Sciences$2.17−8.82%————$66.9MCompare
NTRBNutriband$6.09−3.10%+53.5%−29.7%−201.3%—$74.1MCompare
LAKELakeland Industries$8.96+0.22%−7.0%−4.5%−9.8%—$89.0MCompare
MLSSMilestone Scientific$0.3170+4.31%−21.4%+22.3%−37.3%—$28.7MCompare
INGNInogen$7.29+3.85%+2.5%+3.0%−4.0%—$193.5MCompare

Quick answers

What does Alpha Pro Tech do?
Alpha Pro Tech Ltd is in the business of protecting people, products, and environments. It is developing, manufacturing, and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical, and dental markets.
What is APT's market cap?
$58.28M, based on the Nov 4 close of $5.71.
What is APT's P/E ratio?
13.9× trailing-twelve-month earnings of $4.20M.
Does Alpha Pro Tech pay a dividend?
No regular cash dividend has been paid in the last year.
How much of APT is sold short?
82.9K shares, 1.0% of float, as of Oct 15, 2026.
What sector is APT in?
Healthcare, in the Orthopedic & Surgical Supplies industry.

About Alpha Pro Tech

Alpha Pro Tech Ltd is in the business of protecting people, products, and environments. It is developing, manufacturing, and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical, and dental markets. It also manufactures a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply, consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment, and synthetic roof underlayment accessories.

HQ: Aurora, 122 employeesListed Dec 27, 1994alphaprotech.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology